Research Projects
COVID-19 Testing Disparities
RADx® Underserved Populations (RADx-UP) – [Project Start Date: 09/01/2022, Project End Date: 6/30/2024] Dr. Frietze (Principal Investigator) and Dr. Bibiana Mancera (Co-PI) were recently awarded $307,619 to develop bilingual COVID-19 rapid test instructions and pilot test the instructions using a small randomized control trial (RCT).
COVID-19 Antigen Rapid Test Videos:
https://www.youtube.com/watch?v=lGMw2egh9Mk
https://www.youtube.com/watch?v=JDfdzJlhhA8
Cancer Disparities among Hispanics
Cancer Prevention Research Institute of Texas (CPRIT) – [Project Start Date: 09/01/2021, Project End Date: 08/31/2024] Dr. Frietze was recently awarded $238,619 to help prevent Human Papillomavirus (HPV) associated cancers by employing a randomized control trial investigating trustworthy messengers of the HPV vaccine. Dr. Frietze is working on this project with his mentor from the University of Texas MD Anderson Cancer Center, Dr. Surendranath S. Shastri, M.B.B.S, M.D., D.Ph.
Interdisciplinary Research Teams
Upcoming Studies
The HCRP lab plans to initiate studies in the upcoming year within the following three areas:
Situations of Varying Urgency that Encourage Driving Under the Influence of Small Amounts of Marijuana and Alcohol (DUI-SAMA). Our lab plans to conduct 2-3 studies investigating situations that may encourage DUI-SAMA with goals of identifying three categories: 1) urgent conditions that encourage DUI-SAMA, 2) semi-urgent conditions that encourage DUI-SAMA, and 3) non-urgent conditions that encourage DUI-SAMA. The HCRP lab is currently seeking a UTEP student who is interested in gaining research experience through involvement in this project. Please contact Dr. Frietze (gafrietze@utep.edu) if you are interested and mention this project.
Perceptions of Risk Associated with Legal and Illegal Cannabinoids. Our lab plans to initiate 1-2 pilot studies investigating our communities perceptions of risk associated with various cannabinoids including Delta-8 Tetrahydrocannabinol (THC), Delta-9 THC, Delta-10 THC, THC-O, and Cannabidiol (CBD). The preference and perceived risks of various consumption methods (e.g., combustible, vaporized, ingestion, topical, and sublingual) will be explored. The HCRP lab is currently seeking a UTEP student who is interested in gaining research experience through involvement in this project. Please contact Dr. Frietze (gafrietze@utep.edu) if you are interested and mention this project.
Nootropics. Our lab plans to conduct 1-2 pilot studies examining the use of cognitive enhancing drugs in college students to better understand self-reported effects. We will explore a number of cognitive enhancing drugs including: phosphatidylserine, dimethyleaminoethanol, piracetam, l-theanine, caffeine, adderall and ritalin. The HCRP lab is currently seeking a UTEP student who is interested in gaining research experience through involvement in this project. Please contact Dr. Frietze (gafrietze@utep.edu) if you are interested and mention this project.
Spanish video we developed to increase COVID-19 Rapid testing in our community:
English video we developed to increase COVID-19 Rapid testing in our community: